Study finds Covaxin effective against the UK variant
The sera from people vaccinated with Covaxin were tested against the same strain used for making the vaccine, another strain found in India but different from the one used for…
Category: Bharat Biotech International
Indian scientists divided over restricted use approval for Covaxin
In a tweet on January 14, the Health Ministry said both Covishield and Covaxin approved for restricted use by the Indian regulator are safe. The Health Ministry released a statement…
Vaccine dilemma: To take or not to take Covaxin
True, in the U.S., vaccines from both Pfizer and Moderna are available and recipients, who are health-care workers and nursing home residents, have no option to choose the vaccine. In…
Serious violations in Covaxin trial in Bhopal show nothing has changed since the egregious HPV vaccine trial
The phase-3 clinical trial of Bharat Biotech’s COVID-19 vaccine, Covaxin, by a private hospital in the Bhopal-based Peoples College of Medical Sciences & Research Centre appears to suffer from serious…
I would not take Covaxin without efficacy data: Gagandeep Kang
Scientists, manufacturers and drug regulators have been speeding up the timelines to develop, test and approve vaccines for emergency use. Three safe and efficacious vaccines from Pfizer, Moderna and AstraZeneca…
With hasty approval, India squanders an opportunity to build trust in COVID-19 vaccine
Transparency in the approval process is vital for gaining the trust of people so that they don’t hesitate to take the vaccine. If there is already some degree of anxiety…
Why a dry run for COVID vaccination is needed
This is the first time a vaccine to be administered outside the universal immunisation programme and specifically for adults is to be rolled out. Since several aspects of the COVID vaccination programme are new, the government has rightly decided to undertake a dry-run for vaccine administration.
COVID-19: Ethical challenges of vaccinating people with comorbidities
Unlike in other groups, national databases of people with comorbidities are not available. However, though not comprehensive, since 2010, State governments have been conducting population-based district level screening to detect…
